Ditchcarbon
  • Customers
  1. Organizations
  2. Acino
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 10 days ago

Acino

Company website

Acino, officially known as Acino Pharma AG, is a prominent player in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 2007, the company has rapidly expanded its operations across Europe, the Middle East, and Africa, establishing a strong presence in these key regions. Acino focuses on developing and manufacturing high-quality generic and specialty pharmaceuticals, with a particular emphasis on innovative drug delivery systems. Their unique approach to formulation and packaging sets them apart in a competitive market. With a commitment to improving patient outcomes, Acino has achieved significant milestones, including numerous product launches and strategic partnerships. The company is recognised for its robust portfolio and dedication to quality, positioning it as a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Acino's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Acino's score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Acino's reported carbon emissions

In 2023, Acino reported total carbon emissions of approximately 8,256,500 kg CO2e globally, comprising 5,047,200 kg CO2e from Scope 1 and 3,209,000 kg CO2e from Scope 2 emissions. In Switzerland, Acino's emissions were about 2,787,000 kg CO2e, all from Scope 1, with no reported Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Acino is committed to achieving carbon neutrality by 2050, with ongoing efforts initiated in 2023 to understand and manage its Scope 1 and Scope 2 emissions. This long-term goal reflects a strategic approach to sustainability, aiming to implement activities that will significantly reduce their carbon footprint over the coming decades. The emissions data reported by Acino is cascaded from its parent company, Acino International AG, indicating a corporate family relationship that influences its sustainability reporting and targets.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
5,047,200
Scope 2
3,209,000
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Acino's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Acino is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Acino is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Amoun Pharmaceutical Company S.A.E.

EG
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sanofi SA

CH
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Aug Pharma System

EG
Updated 13 days ago

Pharco Pharmaceuticals Inc.

EG
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Tabuk Pharmaceutical Manufacturing Company

SA
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy